Program: Tuesday, March 2
Tuesday, March 2
- Keynote Session 4
- Major Symposia 5-6
- Measuring TCR Recognition of Antigen at Scale
- Mechanisms of Response and Resistance – Towards More Effective Immunotherapies
- Spotlight on Proffered Papers Sessions 3-4
- Poster Session C / Exhibit Show
- Major Symposia 7-8
- Beyond Conventional Cell Therapy – Emerging Technologies for Precision Immunotherapy
- New Advances in TIL Therapy
- Spotlight Sessions 1-2
- Generative Design of Immune Receptors / Protein Design
- Precision Targets for Solid Tumors: Neoantigens, Fusion-Driven Antigens, and the Dark Genome
- Spotlight Sessions 3-4
- Immune Cell Interactions in the TME / The Myeloid–Stromal Connection in Tumor Immunity and Therapy Resistance
- Non-MHC-Restricted Anti-Tumour Immunity
Breakfast
7-8 a.m. | Diamond Ballroom 1-3
Keynote Session 4
8-9:15 a.m. | Diamond Ballroom 5-10
- 8 a.m. | Keynote Speaker
Michael Birnbaum, Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts - 8:25 a.m. | Keynote Speaker
Tak W. Mak, University of Toronto, Toronto, Ontario, Canada - 8:50 a.m. | Discussion / Q&A
Break
9:15-9:30 a.m. | Diamond Ballroom Foyer
Major Symposia 5-6
9:30-11 a.m.
Major Symposium 5: Measuring TCR Recognition of Antigen at Scale
Diamond Ballroom 5-10
Session Chair: Ton N. Schumacher, Netherlands Cancer Institute, Amsterdam, Netherlands
- 9:30 a.m. | Speaker to be announced
- 9:50 a.m. | Dirk Busch, Technical University of Munich, Germany
- 10:10 a.m | Large-scale priming of T cells for parallel identification of TCR-pMHC pairs
Johanna Olweus, Oslo University Hospital, Norway - 10:30 a.m. | Discussion / Q&A
Major Symposium 6: Mechanisms of Response and Resistance – Towards More Effective Immunotherapies
Diamond Ballroom 4
Break
11-11:15 a.m. | Diamond Ballroom Foyer
Spotlight on Proffered Papers Sessions 3-4
11:15 a.m.-12 p.m.
Proffered Papers Session 3
Diamond Ballroom 5-10
Session Chair: Nina Bhardwaj, Icahn School of Medicine at Mount Sinai, New York, New York
Proffered Papers Session 4
Diamond Ballroom 4
Session Chair: Elizabeth M. Jaffee, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Poster Session C / Exhibit Show / Lunch
12-2:45 p.m. | Platinum Ballroom
Major Symposia 7-8
3-4:30 p.m.
Major Symposium 7: Beyond Conventional Cell Therapy – Emerging Technologies for Precision Immunotherapy
Diamond Ballroom 5-10
Session Chair: Justin Eyquem, University of California, San Francisco, California
- 3 p.m. | Justin Eyquem
- 3:20 p.m. | Speaker to be announced
- 3:40 p.m. | Speaker to be announced
- 4 p.m. | Discussion / Q&A
Major Symposium 8: New Advances in TIL Therapy
Diamond Ballroom 4
Session Chair: James C. Yang, National Cancer Institute, Bethesda, Maryland
- 3 p.m. | James C. Yang
- 3:20 p.m. | Speaker to be announced
- 3:40 p.m. | Speaker to be announced
- 4 p.m. | Discussion / Q&A
Break
4:30-4:45 p.m. | Diamond Ballroom Foyer
Spotlight Sessions 1-2
4:45-5:40 p.m.
Spotlight Session 1: Generative Design of Immune Receptors / Protein Design
Diamond Ballroom 5-10
Spotlight Session 2: Precision Targets for Solid Tumors: Neoantigens, Fusion-Driven Antigens, and the Dark Genome
Diamond Ballroom 4
Session Chair: Bernard A. Fox, Earle A Chiles Research Institute, Renton, Washington
- 4:45 p.m. | Bernard A. Fox
- 5:05 p.m. | Speaker to be announced
- 5:25 p.m. | Discussion / Q&A
Spotlight Sessions 3-4
5:45-6:40 p.m.
Spotlight Session 3: Immune Cell Interactions in the TME / The Myeloid–Stromal Connection in Tumor Immunity and Therapy Resistance
Diamond Ballroom 5-10
Session Chair: Daniel Peeper, Netherlands Cancer Institute, Amsterdam, The Netherlands
- 5:45 p.m. | Daniel Peeper
- 6:05 p.m. | Amanda Lund, NYU Grossman School of Medicine, New York, New York
- 6:25 p.m. | Discussion / Q&A
Spotlight Session 4: Non-MHC-Restricted Anti-Tumour Immunity
Diamond Ballroom 4
Session Chair: Adrian Hayday, The Francis Crick Institute, London, United Kingdom
- 5:45 p.m. | Adrian Hayday
- 6:05 p.m. | Speaker to be announced
- 6:25 p.m. | Discussion / Q&A
Evening off / Dinner on own
6:40 p.m.